MRI-guided infusions are now being used in a current clinical trial of AAV2-brain derived neurotrophic factor (AAV2-BDNF) gene therapy in patients with mild AD and MCI (NCT05040217). This evidence concerns the gene BDNF and Alzheimer disease.